Salo, Finland – June 2025 — Lindo is pleased to announce the signing of a new distribution and licensing agreement with Spectral Blue by LED Tailor, marking an important step forward in the partnership between the two companies.
The agreement was formalised last week at Spectral Blue by LED Tailor’s headquarters in Salo, Finland, where Lindo Founder and CEO Robert Gangi met with Michel Schmidt, CEO of LED Tailor.
This moment represents more than just a contract — it reflects the strengthening of a relationship that has been steadily building over time. Lindo and LED Tailor have worked together in various capacities, and this next step brings even greater clarity and momentum to their shared mission.
At Lindo, the focus is on delivering medical innovations that elevate patient care and infection prevention globally. Spectral Blue’s world-leading MWHI® antimicrobial blue light (aBL) technology is a natural complement to Lindo’s design-led, evidence-driven approach.
“This partnership enhances our ability to move faster, scale smarter, and deliver global impact where it matters most — on the front lines of healthcare,” said Robert Gangi. “We’re excited to deepen our collaboration with a team that shares our belief in sustainable, light-based solutions that prevent harm before it happens.”
Special thanks were extended to Michel Schmidt and Tuukka Autio of LED Tailor for their hospitality and vision. The energy in the room during the signing was a strong reminder: when the right people come together with a common purpose, progress is inevitable.
This strengthened partnership positions Lindo and Spectral Blue to accelerate the adoption of sustainable disinfection technologies that protect patients, reduce healthcare-associated infections (HAIs), and improve outcomes worldwide.